We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TAIPY market cap is 3.94B. The company's latest EPS is JPY 57.9278 and P/E is 1.02.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 261.55B | 288.53B | 281.98B | 268.2B | 301.38B |
| Operating Income | 29.98B | 21.14B | 17.94B | 10.78B | 23.24B |
| Net Income | 48.59B | 20.53B | 13.32B | 13.12B | 19B |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 821.78B | 853.05B | 876.92B | 888.16B | 941.49B |
| Total Liabilities | 97.65B | 111.34B | 118.52B | 120.2B | 132.15B |
| Total Equity | 724.14B | 741.71B | 758.41B | 767.96B | 809.34B |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 19.22B | 41.99B | 42.03B | 28.51B | 40.97B |
| Investing | 66.05B | -107.08B | -1.96B | -7.06B | -27.13B |
| Financing | -15.47B | -11.7B | -11.35B | -10.06B | -10.88B |
| Market Cap | 3.94B |
| Price to Earnings Ratio | 1.02 |
| Price to Sales Ratio | 0.06 |
| Price to Cash Ratio | 0.08 |
| Price to Book Ratio | 0.02 |
| Dividend Yield | - |
| Shares Outstanding | 327.94M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Taisho Pharmaceutical Holdings Company Ltd (CE) |
| Address |
3-24-1, takada toshima, tokyo 170-8655 |
| Website | https://www.taisho-holdings.co.jp |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
